Raymond J Steptoe

researcher ORCID ID = 0000-0002-6513-6406

Raymond J Steptoe is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-6513-6406
P1053ResearcherIDB-3843-2011
P1153Scopus author ID6701551792

P69educated atUniversity of Western AustraliaQ1517021
P108employerUniversity of QueenslandQ866012
P735given nameRaymondQ2127728
RaymondQ2127728
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q42403489A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin
Q48282619APC-targeted proinsulin expression inactivates insulin-specific memory CD8+ T cells in NOD mice.
Q33752348Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation
Q40152307Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8+ T-cell priming to tolerance in autoimmune-prone NOD mice
Q39933853Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection
Q46098672Antigen-specific suppression of inflammatory arthritis using liposomes.
Q30825112Asymmetric peptide dendrimers are effective linkers for antibody-mediated delivery of diverse payloads to b cells in vitro and in vivo
Q81333474Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells
Q35151883Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment
Q26821885CD4+/CD8+ double-positive T cells: more than just a developmental stage?
Q46346459CD4+CD8β+ double-positive T cells in skin-draining lymph nodes respond to inflammatory signals from the skin
Q37692502CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?
Q38094489Cell-based therapies for ocular inflammation.
Q59400577Choroidal mast cell dynamics during experimental autoimmune uveoretinitis in rat strains of differing susceptibility
Q58037249Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma
Q73841142Comparative analysis of dendritic cell density and total number in commonly transplanted organs: morphometric estimation in normal mice
Q41113510Dendritic cells and tolerance induction.
Q34601754Dendritic cells in the thymus contribute to T-regulatory cell induction
Q37305500Distribution and characterisation of rat choroidal mast cells.
Q74310351Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow
Q48524416Flt-3L expansion of recipient CD8α+ dendritic cells deletes alloreactive donor T cells and represents an alternative to post-transplant cyclophosphamide for the prevention of GVHD.
Q57134204Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development
Q35832735HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions.
Q57252622Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets
Q34553749Immunobiology of liver dendritic cells.
Q41869061Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation.
Q44638428Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation
Q77794913Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow
Q27003955Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?
Q39064359In vivo comparison of local versus systemic delivery of immunostimulating siRNA in HPV-driven tumours.
Q38050613Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease?
Q34448684Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy
Q83476294Low-generation asymmetric dendrimers exhibit minimal toxicity and effectively complex DNA
Q58758033MHC Class II Expression Is Regulated in Dendritic Cells Independently of Invariant Chain Degradation
Q38851939Maintenance of peripheral tolerance to islet antigens.
Q52104466Most lymphoid organ dendritic cell types are phenotypically and functionally immature.
Q59310635Origin and steady-state turnover of major histocompatibility complex Class II-positive dendritic cells and resident-tissue macrophages in the iris of the rat eye
Q97691639Peripheral Tolerance Checkpoints Imposed by Ubiquitous Antigen Expression Limit Antigen-Specific B Cell Responses under Strongly Immunogenic Conditions
Q44778818Persistence of recipient lymphocytes in NOD mice after irradiation and bone marrow transplantation.
Q35102415Proinsulin is encoded by an RNA splice variant in human blood myeloid cells.
Q45874675Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.
Q53210404Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.
Q41157946Regulatory T cells prevent inducible BALT formation by dampening neutrophilic inflammation.
Q73306177Resident tissue macrophages within the normal rat iris lack immunosuppressive activity and are effective antigen-presenting cells
Q42069114Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.
Q90407229Simple, rapid and inexpensive typing of common HLA class I alleles for immunological studies
Q51057483Steady-state antigen-expressing dendritic cells terminate CD4+ memory T-cell responses.
Q84185759Steady-state dendritic cells continuously inactivate T cells that escape thymic negative selection
Q57667259Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses
Q45264704Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity
Q44234403Targeting antigen to diverse APCs inactivates memory CD8+ T cells without eliciting tissue-destructive effector function
Q52332752Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt Signaling.
Q52639174Tetramer-based identification of naïve antigen-specific B cells within a polyclonal repertoire.
Q40573262The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma.
Q48003839The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
Q44649101The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation.
Q77900345Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection
Q48383341Ultrastructural pathology of experimental autoimmune uveitis in the rat.
Q33590483c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells
Q35962433γδ T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen

Search more.